Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 321

1.

Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.

Gressner OA, Fang M, Li H, Lu LG, Gressner AM, Gao CF.

Clin Chim Acta. 2013 Jun 5;421:126-31. doi: 10.1016/j.cca.2013.02.029. Epub 2013 Mar 15.

PMID:
23501329
[PubMed - indexed for MEDLINE]
2.

Connective tissue growth factor reacts as an IL-6/STAT3-regulated hepatic negative acute phase protein.

Gressner OA, Peredniene I, Gressner AM.

World J Gastroenterol. 2011 Jan 14;17(2):151-63. doi: 10.3748/wjg.v17.i2.151.

PMID:
21245987
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Increased serum xylosyltransferase activity in patients with liver fibrosis.

Kuhn J, Gressner OA, Götting C, Gressner AM, Kleesiek K.

Clin Chim Acta. 2009 Nov;409(1-2):123-6. doi: 10.1016/j.cca.2009.09.013. Epub 2009 Sep 13.

PMID:
19755118
[PubMed - indexed for MEDLINE]
4.

Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis.

Gressner OA, Beer N, Jodlowski A, Gressner AM.

Clin Chim Acta. 2009 Nov;409(1-2):90-5. doi: 10.1016/j.cca.2009.09.005. Epub 2009 Sep 10.

PMID:
19748500
[PubMed - indexed for MEDLINE]
5.

BMP-7 as antagonist of organ fibrosis.

Weiskirchen R, Meurer SK, Gressner OA, Herrmann J, Borkham-Kamphorst E, Gressner AM.

Front Biosci (Landmark Ed). 2009 Jun 1;14:4992-5012. Review.

PMID:
19482601
[PubMed - indexed for MEDLINE]
6.

Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.

Gressner AM, Gao CF, Gressner OA.

World J Gastroenterol. 2009 May 28;15(20):2433-40.

PMID:
19468990
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Inverse association between serum concentrations of actin-free vitamin D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma.

Gressner OA, Gao C, Siluschek M, Kim P, Gressner AM.

Eur J Gastroenterol Hepatol. 2009 Sep;21(9):990-5. doi: 10.1097/MEG.0b013e3283293769.

PMID:
19322100
[PubMed - indexed for MEDLINE]
8.

Intraperitoneal application of caffeine prevents D-galactosamine-induced hepatic expression of connective tissue growth factor (CTGF/CCN2) in the rat.

Gressner OA, Siluschek M, Lahme B, Gressner AM.

J Hepatol. 2009 May;50(5):1053-5. doi: 10.1016/j.jhep.2009.02.001. Epub 2009 Mar 3. No abstract available. Retraction in: J Hepatol. 2010 Sep;53(3):590.

PMID:
19321219
[PubMed - indexed for MEDLINE]
9.

Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling.

Gressner OA, Lahme B, Siluschek M, Rehbein K, Weiskirchen R, Gressner AM.

Hepatology. 2009 Jun;49(6):2021-30. doi: 10.1002/hep.22850.

PMID:
19309720
[PubMed - indexed for MEDLINE]
10.

Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells.

Gressner OA, Lahme B, Siluschek M, Gressner AM.

Liver Int. 2009 Jul;29(6):886-97. doi: 10.1111/j.1478-3231.2009.01987.x. Epub 2009 Mar 5.

PMID:
19291178
[PubMed - indexed for MEDLINE]
11.

Secreted cysteine-rich FGF receptor derives from posttranslational processing by furin-like prohormone convertases.

Antoine M, Köhl R, Tag CG, Gressner AM, Hellerbrand C, Kiefer P.

Biochem Biophys Res Commun. 2009 May 1;382(2):359-64. doi: 10.1016/j.bbrc.2009.03.026. Epub 2009 Mar 11.

PMID:
19285038
[PubMed - indexed for MEDLINE]
12.

Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease.

Gressner OA, Jafari S, Erkens M, Gao C, Stanzel S, Gressner AM.

Clin Chim Acta. 2009 May;403(1-2):188-93. doi: 10.1016/j.cca.2009.02.017. Epub 2009 Mar 10.

PMID:
19281805
[PubMed - indexed for MEDLINE]
13.

Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis.

Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, Janetzko A, Wiederholt T, Berg T, Müller T, Trautwein C, Gressner AM, Weiskirchen R.

J Viral Hepat. 2009 Sep;16(9):612-20. doi: 10.1111/j.1365-2893.2009.01110.x. Epub 2009 Feb 20.

PMID:
19243500
[PubMed - indexed for MEDLINE]
14.

Expression of E-selectin ligand-1 (CFR/ESL-1) on hepatic stellate cells: implications for leukocyte extravasation and liver metastasis.

Antoine M, Tag CG, Gressner AM, Hellerbrand C, Kiefer P.

Oncol Rep. 2009 Feb;21(2):357-62.

PMID:
19148508
[PubMed - indexed for MEDLINE]
15.

Elevated concentrations of 15-deoxy-Delta12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor gamma-inducing drugs.

Gressner OA, Gao C, Rehbein K, Lahme B, Siluschek M, Berg T, Müller T, Gressner AM.

Liver Int. 2009 May;29(5):730-5. doi: 10.1111/j.1478-3231.2008.01895.x. Epub 2008 Oct 15.

PMID:
19018984
[PubMed - indexed for MEDLINE]
16.

Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells.

Roderfeld M, Weiskirchen R, Atanasova S, Gressner AM, Preissner KT, Roeb E, Kanse SM.

Liver Int. 2009 May;29(5):686-91. doi: 10.1111/j.1478-3231.2008.01897.x. Epub 2008 Oct 15.

PMID:
19018983
[PubMed - indexed for MEDLINE]
17.

Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: relationship to S-100B levels and blood-brain barrier function.

Gressner OA, Schifflers MC, Kim P, Heuts L, Lahme B, Gressner AM.

Clin Chim Acta. 2009 Feb;400(1-2):86-90. doi: 10.1016/j.cca.2008.10.015. Epub 2008 Oct 30.

PMID:
19000909
[PubMed - indexed for MEDLINE]
18.

Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases.

Gressner OA, Gressner AM.

Liver Int. 2008 Sep;28(8):1065-79. doi: 10.1111/j.1478-3231.2008.01826.x. Review.

PMID:
18783549
[PubMed - indexed for MEDLINE]
19.

Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury.

Borkham-Kamphorst E, Kovalenko E, van Roeyen CR, Gassler N, Bomble M, Ostendorf T, Floege J, Gressner AM, Weiskirchen R.

Lab Invest. 2008 Oct;88(10):1090-100. doi: 10.1038/labinvest.2008.71. Epub 2008 Jul 28.

PMID:
18663351
[PubMed - indexed for MEDLINE]
Free Article
20.

Maternal factor V Leiden mutation is associated with HELLP syndrome in Caucasian women.

Muetze S, Leeners B, Ortlepp JR, Kuse S, Tag CG, Weiskirchen R, Gressner AM, Rudnik-Schoeneborn S, Zerres K, Rath W.

Acta Obstet Gynecol Scand. 2008;87(6):635-42. doi: 10.1080/00016340802112740.

PMID:
18568463
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk